Showing 1 - 13 results of 13 for search 'Riad El Fakih', query time: 0.05s Refine Results
  1. 1
    Targeting FLT3 Mutations in Acute Myeloid Leukemia

    Targeting FLT3 Mutations in Acute Myeloid Leukemia by Riad El Fakih, Walid Rasheed, Yousef Hawsawi, Maamoun Alsermani, Mona Hassanein

    Published 2018-01-01
    Get full text
    Article
  2. 2
    P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE.

    P788: OUTCOME OF SEVERE APLASTIC ANEMIA TREATED WITH ALLOGENIC STEM CELL TRANSPLANTATION COMPARED WITH IMMUNOSUPPRESSIVE THERAPY AS FIRST LINE. by Alfadil Haroon, Riad El Fakih, Mahmoud Aljurf, Mohammed Isam Sharif, Tusneem Elhassan, Hazzaa Alzahrani

    Published 2023-08-01
    Get full text
    Article
  3. 3
    A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL

    A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL by Ruah Alyamany, Riad El Fakih, Ahmed Alnughmush, Abdulwahab Albabtain, Mohamed A. Kharfan-Dabaja, Mahmoud Aljurf

    Published 2024-03-01
    Get full text
    Article
  4. 4
    Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas

    Clinical, Diagnostic and Prognostic Characteristics of Primary Cutaneous Gamma Delta T-cell Lymphomas by Ibrahim N. Muhsen, Riad El Fakih, Mehdi Hamadani, Hillard M. Lazarus, Mohamed A. Kharfan-Dabaja, Mahmoud Aljurf

    Published 2022-06-01
    Get full text
    Article
  5. 5
    Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib – Case report

    Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib – Case report by Aisling Barrett, Toby A. Eyre, Shaheel Bhuva, Mahmoud Aljurf, Riad El Fakih, Mohammad A. Ashshi, Alfadel Alshaibani

    Published 2024-02-01
    Get full text
    Article
  6. 6
    Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma

    Recent Advances in Diagnosis and Therapy of Angioimmunoblastic T Cell Lymphoma by Mostafa F. Mohammed Saleh, Ahmed Kotb, Ghada E. M. Abdallah, Ibrahim N. Muhsen, Riad El Fakih, Mahmoud Aljurf

    Published 2021-12-01
    Get full text
    Article
  7. 7
    Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade

    Survival Outcome of Empirical Antifungal Therapy and the Value of Early Initiation: A Review of the Last Decade by Souha S. Kanj, Ali S. Omrani, Hail M. Al-Abdely, Ahmad Subhi, Riad El Fakih, Ibraheem Abosoudah, Hazar Kanj, George Dimopoulos

    Published 2022-10-01
    Get full text
    Article
  8. 8
    The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes

    The role of androgen therapy in acquired aplastic anemia and other bone marrow failure syndromes by Momen Nassani, Riad El Fakih, Jakob Passweg, Simone Cesaro, Hazzaa Alzahrani, Ali Alahmari, Carmem Bonfim, Raheel Iftikhar, Amal Albeihany, Constantijn Halkes, Syed Osman Ahmed, Carlo Dufour, Mahmoud Aljurf

    Published 2023-05-01
    Get full text
    Article
  9. 9
    OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY

    OUTCOME OF APLASTIC ANEMIA ACCORDING TO DISEASE SEVERITY by Alfadil Haroon, Syed Osman Ahmed Ahmed, Hazzaa Alzahrani, Riad El Fakih, Ali Alahmari, Alfadel Alshaibani, Naeem Chaudhri, Fahad Almohareb, Saud Alhayli, Marwan Shaheen, Abdulwahab Albabtain, Fahad Alsharif, Feras Alfraih, Walid Rasheed, Mahmoud Aljurf

    Published 2023-10-01
    Get full text
    Article
  10. 10
    The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities

    The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities by Mona Hassanein, Riad El Fakih, Walid Rasheed, Syed Ahmed, Marwan Shaheen, Naeem Chaudhri, Fahad Alsharif, Shad Ahmed, Amr Hanbali, Alfadel AlShaibani, Feras Alfraih, Saud Alhayli, Tusneem Elhassan, Ali Alahmari, Hazzaa Alzahrani, Fahad Almohareb, Mahmoud Aljurf, Shahrukh Hashmi

    Published 2021-05-01
    Get full text
    Article
  11. 11
    Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center

    Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of... by Amr Hanbali, Ahmed Kotb, Riad El Fakih, Feras Alfraih, Syed Osman Ahmed, Marwan Shaheen, Saud Alhayli, Ali Alahmari, Ahmad Alotaibi, Alfadel Alshaibani, Mahmoud Abu Riash, Farah Deeba, Maryam Asif, Walid Rasheed, Hazzaa Alzahrani, Fahad Alsharif, Naeem Chaudhri, Fahad Almohareb, Mahmoud Aljurf

    Published 2021-01-01
    Get full text
    Article
  12. 12
    Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East

    Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East by Maria Dimou, Mohamed Abuzakouk, Mona Al Ahmad, Khalil Al Farsi, Ahmad Alhuraiji, Fayhan Al Roqi, Fayhan Al Roqi, Fayhan Al Roqi, Ahmed Alsaeed, Ahmed Alsaeed, Ahmed Alsaeed, Mohsen Alzahrani, Mohsen Alzahrani, Mohsen Alzahrani, Ali Bazarbachi, Honar Cherif, Riad El Fakih, Carla Irani, Faraz Khan, Iman Nasr, Hani Yousif Osman, Mustaqeem Siddiqui

    Published 2024-03-01
    Get full text
    Article
  13. 13
    Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age multiple myeloma patients

    Improved long-term survival rate in the responders to bortezomib, cyclophosphamide, dexamethasone induction therapy in a transplant-eligible cohort of predominantly middle-age mult... by Ahmed Kotb Abdrabou, Fahad Al Sharif, Riad El Fakih, Hazaa Al Zahrani, Ruah Al Yamany, Mostafa Saleh, Saud Alhayli, Zakia Al Somali, Ahmad Alotaibi, AlFadel AlShaibani, Farah Deeba, Maryam Asif, Syed Ahmed Osman Ali Ahmed, Feras Al Fraih, Marwan Shaheen, Ali Alahmari, Walid Rasheed, Naeem Arshad Chaudhri, Fahad Al Mohareb, Mahmoud Aljurf, Amr Hanbali

    Published 2024-03-01
    Get full text
    Article

Search Tools: